COVID-19 Impact on Human Immunodeficiency Virus Testing Market, Global Research Reports 2020-2021
This report covers market size and forecasts of Human Immunodeficiency Virus Testing, including the following market information:
Major competitors identified in this market include Roche, Abbott, Bio-Rad, WanTai BioPharm, Beckman Coulter, BD, Kehua, Livzon, Intec, ThermoFisher, Biokit, Nectar Lifesciences, ELITech Group, Chembio Diagnostic Systems, Trinity Biotech, etc.
Based on the Region:
- Global Human Immunodeficiency Virus Testing Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million)
- Global Human Immunodeficiency Virus Testing Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million)
- Global Human Immunodeficiency Virus Testing Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million)
- Global Human Immunodeficiency Virus Testing Market Size by Company, 2019- 2020 (quarterly data), (US$ Million)
Major competitors identified in this market include Roche, Abbott, Bio-Rad, WanTai BioPharm, Beckman Coulter, BD, Kehua, Livzon, Intec, ThermoFisher, Biokit, Nectar Lifesciences, ELITech Group, Chembio Diagnostic Systems, Trinity Biotech, etc.
Based on the Region:
- Asia-Pacific (China, Japan, South Korea, India and ASEAN)
- North America (US and Canada)
- Europe (Germany, France, UK and Italy)
- Rest of World (Latin America, Middle East & Africa)
- Antibody Tests
- RNA (viral load) Test
- Antibody-antigen Test
- Diagnostic Centers
- Hospitals
- Home Use
1.1 Research Scope
1.2 Market Segmentation
1.3 Research Objectives
1.4 Research Methodology
1.4.1 Research Process
1.4.2 Data Triangulation
1.4.3 Research Approach
1.4.4 Base Year
1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.5.2 Covid-19 Impact: Commodity Prices Indices
1.5.3 Covid-19 Impact: Global Major Government Policy
1.6 The Covid-19 Impact on Human Immunodeficiency Virus Testing Industry
1.7 COVID-19 Impact: Human Immunodeficiency Virus Testing Market Trends
2 GLOBAL HUMAN IMMUNODEFICIENCY VIRUS TESTING QUARTERLY MARKET SIZE ANALYSIS
2.1 Human Immunodeficiency Virus Testing Business Impact Assessment - COVID-19
2.1.1 Global Human Immunodeficiency Virus Testing Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.2 Global Human Immunodeficiency Virus Testing Quarterly Market Size 2020-2021
2.3 COVID-19-Driven Market Dynamics and Factor Analysis
2.3.1 Drivers
2.3.2 Restraints
2.3.3 Opportunities
2.3.4 Challenges
3 QUARTERLY COMPETITIVE ASSESSMENT, 2020
3.1 By Players, Global Human Immunodeficiency Virus Testing Quarterly Market Size, 2019 VS 2020
3.2 By Players, Human Immunodeficiency Virus Testing Headquarters and Area Served
3.3 Date of Key Players Enter into Human Immunodeficiency Virus Testing Market
3.4 Key Players Human Immunodeficiency Virus Testing Product Offered
3.5 Mergers & Acquisitions, Expansion Plans
4 IMPACT OF COVID-19 ON HUMAN IMMUNODEFICIENCY VIRUS TESTING SEGMENTS, BY TYPE
4.1 Introduction
1.4.1 Antibody Tests
1.4.2 RNA (viral load) Test
1.4.3 Antibody-antigen Test
4.2 By Type, Global Human Immunodeficiency Virus Testing Market Size, 2019-2021
5 IMPACT OF COVID-19 ON HUMAN IMMUNODEFICIENCY VIRUS TESTING SEGMENTS, BY APPLICATION
5.1 Overview
5.5.1 Diagnostic Centers
5.5.2 Hospitals
5.5.3 Home Use
5.2 By Application, Global Human Immunodeficiency Virus Testing Market Size, 2019-2021
5.2.1 By Application, Global Human Immunodeficiency Virus Testing Market Size by Application, 2019-2021
6 GEOGRAPHIC ANALYSIS
6.1 Introduction
6.2 North America
6.2.1 Macroeconomic Indicators of US
6.2.2 US
6.2.3 Canada
6.3 Europe
6.3.1 Macroeconomic Indicators of Europe
6.3.2 Germany
6.3.3 France
6.3.4 UK
6.3.5 Italy
6.4 Asia-Pacific
6.4.1 Macroeconomic Indicators of Asia-Pacific
6.4.2 China
6.4.3 Japan
6.4.4 South Korea
6.4.5 India
6.4.6 ASEAN
6.5 Rest of World
6.5.1 Latin America
6.5.2 Middle East and Africa
7 COMPANY PROFILES
7.1 Roche
7.1.1 Roche Business Overview
7.1.2 Roche Human Immunodeficiency Virus Testing Quarterly Revenue, 2020
7.1.3 Roche Human Immunodeficiency Virus Testing Product Introduction
7.1.4 Roche Response to COVID-19 and Related Developments
7.2 Abbott
7.2.1 Abbott Business Overview
7.2.2 Abbott Human Immunodeficiency Virus Testing Quarterly Revenue, 2020
7.2.3 Abbott Human Immunodeficiency Virus Testing Product Introduction
7.2.4 Abbott Response to COVID-19 and Related Developments
7.3 Bio-Rad
7.3.1 Bio-Rad Business Overview
7.3.2 Bio-Rad Human Immunodeficiency Virus Testing Quarterly Revenue, 2020
7.3.3 Bio-Rad Human Immunodeficiency Virus Testing Product Introduction
7.3.4 Bio-Rad Response to COVID-19 and Related Developments
7.4 WanTai BioPharm
7.4.1 WanTai BioPharm Business Overview
7.4.2 WanTai BioPharm Human Immunodeficiency Virus Testing Quarterly Revenue, 2020
7.4.3 WanTai BioPharm Human Immunodeficiency Virus Testing Product Introduction
7.4.4 WanTai BioPharm Response to COVID-19 and Related Developments
7.5 Beckman Coulter
7.5.1 Beckman Coulter Business Overview
7.5.2 Beckman Coulter Human Immunodeficiency Virus Testing Quarterly Revenue, 2020
7.5.3 Beckman Coulter Human Immunodeficiency Virus Testing Product Introduction
7.5.4 Beckman Coulter Response to COVID-19 and Related Developments
7.6 BD
7.6.1 BD Business Overview
7.6.2 BD Human Immunodeficiency Virus Testing Quarterly Revenue, 2020
7.6.3 BD Human Immunodeficiency Virus Testing Product Introduction
7.6.4 BD Response to COVID-19 and Related Developments
7.7 Kehua
7.7.1 Kehua Business Overview
7.7.2 Kehua Human Immunodeficiency Virus Testing Quarterly Revenue, 2020
7.7.3 Kehua Human Immunodeficiency Virus Testing Product Introduction
7.7.4 Kehua Response to COVID-19 and Related Developments
7.8 Livzon
7.8.1 Livzon Business Overview
7.8.2 Livzon Human Immunodeficiency Virus Testing Quarterly Revenue, 2020
7.8.3 Livzon Human Immunodeficiency Virus Testing Product Introduction
7.8.4 Livzon Response to COVID-19 and Related Developments
7.9 Intec
7.9.1 Intec Business Overview
7.9.2 Intec Human Immunodeficiency Virus Testing Quarterly Revenue, 2020
7.9.3 Intec Human Immunodeficiency Virus Testing Product Introduction
7.9.4 Intec Response to COVID-19 and Related Developments
7.10 ThermoFisher
7.10.1 ThermoFisher Business Overview
7.10.2 ThermoFisher Human Immunodeficiency Virus Testing Quarterly Revenue, 2020
7.10.3 ThermoFisher Human Immunodeficiency Virus Testing Product Introduction
7.10.4 ThermoFisher Response to COVID-19 and Related Developments
7.11 Biokit
7.11.1 Biokit Business Overview
7.11.2 Biokit Human Immunodeficiency Virus Testing Quarterly Revenue, 2020
7.11.3 Biokit Human Immunodeficiency Virus Testing Product Introduction
7.11.4 Biokit Response to COVID-19 and Related Developments
7.12 Nectar Lifesciences
7.12.1 Nectar Lifesciences Business Overview
7.12.2 Nectar Lifesciences Human Immunodeficiency Virus Testing Quarterly Revenue, 2020
7.12.3 Nectar Lifesciences Human Immunodeficiency Virus Testing Product Introduction
7.12.4 Nectar Lifesciences Response to COVID-19 and Related Developments
7.13 ELITech Group
7.13.1 ELITech Group Business Overview
7.13.2 ELITech Group Human Immunodeficiency Virus Testing Quarterly Revenue, 2020
7.13.3 ELITech Group Human Immunodeficiency Virus Testing Product Introduction
7.13.4 ELITech Group Response to COVID-19 and Related Developments
7.14 Chembio Diagnostic Systems
7.14.1 Chembio Diagnostic Systems Business Overview
7.14.2 Chembio Diagnostic Systems Human Immunodeficiency Virus Testing Quarterly Revenue, 2020
7.14.3 Chembio Diagnostic Systems Human Immunodeficiency Virus Testing Product Introduction
7.14.4 Chembio Diagnostic Systems Response to COVID-19 and Related Developments
7.15 Trinity Biotech
7.15.1 Trinity Biotech Business Overview
7.15.2 Trinity Biotech Human Immunodeficiency Virus Testing Quarterly Revenue, 2020
7.15.3 Trinity Biotech Human Immunodeficiency Virus Testing Product Introduction
7.15.4 Trinity Biotech Response to COVID-19 and Related Developments
8 KEY FINDINGS
9 APPENDIX
9.1 About US
9.2 Disclaimer
1.2 Market Segmentation
1.3 Research Objectives
1.4 Research Methodology
1.4.1 Research Process
1.4.2 Data Triangulation
1.4.3 Research Approach
1.4.4 Base Year
1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.5.2 Covid-19 Impact: Commodity Prices Indices
1.5.3 Covid-19 Impact: Global Major Government Policy
1.6 The Covid-19 Impact on Human Immunodeficiency Virus Testing Industry
1.7 COVID-19 Impact: Human Immunodeficiency Virus Testing Market Trends
2 GLOBAL HUMAN IMMUNODEFICIENCY VIRUS TESTING QUARTERLY MARKET SIZE ANALYSIS
2.1 Human Immunodeficiency Virus Testing Business Impact Assessment - COVID-19
2.1.1 Global Human Immunodeficiency Virus Testing Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.2 Global Human Immunodeficiency Virus Testing Quarterly Market Size 2020-2021
2.3 COVID-19-Driven Market Dynamics and Factor Analysis
2.3.1 Drivers
2.3.2 Restraints
2.3.3 Opportunities
2.3.4 Challenges
3 QUARTERLY COMPETITIVE ASSESSMENT, 2020
3.1 By Players, Global Human Immunodeficiency Virus Testing Quarterly Market Size, 2019 VS 2020
3.2 By Players, Human Immunodeficiency Virus Testing Headquarters and Area Served
3.3 Date of Key Players Enter into Human Immunodeficiency Virus Testing Market
3.4 Key Players Human Immunodeficiency Virus Testing Product Offered
3.5 Mergers & Acquisitions, Expansion Plans
4 IMPACT OF COVID-19 ON HUMAN IMMUNODEFICIENCY VIRUS TESTING SEGMENTS, BY TYPE
4.1 Introduction
1.4.1 Antibody Tests
1.4.2 RNA (viral load) Test
1.4.3 Antibody-antigen Test
4.2 By Type, Global Human Immunodeficiency Virus Testing Market Size, 2019-2021
5 IMPACT OF COVID-19 ON HUMAN IMMUNODEFICIENCY VIRUS TESTING SEGMENTS, BY APPLICATION
5.1 Overview
5.5.1 Diagnostic Centers
5.5.2 Hospitals
5.5.3 Home Use
5.2 By Application, Global Human Immunodeficiency Virus Testing Market Size, 2019-2021
5.2.1 By Application, Global Human Immunodeficiency Virus Testing Market Size by Application, 2019-2021
6 GEOGRAPHIC ANALYSIS
6.1 Introduction
6.2 North America
6.2.1 Macroeconomic Indicators of US
6.2.2 US
6.2.3 Canada
6.3 Europe
6.3.1 Macroeconomic Indicators of Europe
6.3.2 Germany
6.3.3 France
6.3.4 UK
6.3.5 Italy
6.4 Asia-Pacific
6.4.1 Macroeconomic Indicators of Asia-Pacific
6.4.2 China
6.4.3 Japan
6.4.4 South Korea
6.4.5 India
6.4.6 ASEAN
6.5 Rest of World
6.5.1 Latin America
6.5.2 Middle East and Africa
7 COMPANY PROFILES
7.1 Roche
7.1.1 Roche Business Overview
7.1.2 Roche Human Immunodeficiency Virus Testing Quarterly Revenue, 2020
7.1.3 Roche Human Immunodeficiency Virus Testing Product Introduction
7.1.4 Roche Response to COVID-19 and Related Developments
7.2 Abbott
7.2.1 Abbott Business Overview
7.2.2 Abbott Human Immunodeficiency Virus Testing Quarterly Revenue, 2020
7.2.3 Abbott Human Immunodeficiency Virus Testing Product Introduction
7.2.4 Abbott Response to COVID-19 and Related Developments
7.3 Bio-Rad
7.3.1 Bio-Rad Business Overview
7.3.2 Bio-Rad Human Immunodeficiency Virus Testing Quarterly Revenue, 2020
7.3.3 Bio-Rad Human Immunodeficiency Virus Testing Product Introduction
7.3.4 Bio-Rad Response to COVID-19 and Related Developments
7.4 WanTai BioPharm
7.4.1 WanTai BioPharm Business Overview
7.4.2 WanTai BioPharm Human Immunodeficiency Virus Testing Quarterly Revenue, 2020
7.4.3 WanTai BioPharm Human Immunodeficiency Virus Testing Product Introduction
7.4.4 WanTai BioPharm Response to COVID-19 and Related Developments
7.5 Beckman Coulter
7.5.1 Beckman Coulter Business Overview
7.5.2 Beckman Coulter Human Immunodeficiency Virus Testing Quarterly Revenue, 2020
7.5.3 Beckman Coulter Human Immunodeficiency Virus Testing Product Introduction
7.5.4 Beckman Coulter Response to COVID-19 and Related Developments
7.6 BD
7.6.1 BD Business Overview
7.6.2 BD Human Immunodeficiency Virus Testing Quarterly Revenue, 2020
7.6.3 BD Human Immunodeficiency Virus Testing Product Introduction
7.6.4 BD Response to COVID-19 and Related Developments
7.7 Kehua
7.7.1 Kehua Business Overview
7.7.2 Kehua Human Immunodeficiency Virus Testing Quarterly Revenue, 2020
7.7.3 Kehua Human Immunodeficiency Virus Testing Product Introduction
7.7.4 Kehua Response to COVID-19 and Related Developments
7.8 Livzon
7.8.1 Livzon Business Overview
7.8.2 Livzon Human Immunodeficiency Virus Testing Quarterly Revenue, 2020
7.8.3 Livzon Human Immunodeficiency Virus Testing Product Introduction
7.8.4 Livzon Response to COVID-19 and Related Developments
7.9 Intec
7.9.1 Intec Business Overview
7.9.2 Intec Human Immunodeficiency Virus Testing Quarterly Revenue, 2020
7.9.3 Intec Human Immunodeficiency Virus Testing Product Introduction
7.9.4 Intec Response to COVID-19 and Related Developments
7.10 ThermoFisher
7.10.1 ThermoFisher Business Overview
7.10.2 ThermoFisher Human Immunodeficiency Virus Testing Quarterly Revenue, 2020
7.10.3 ThermoFisher Human Immunodeficiency Virus Testing Product Introduction
7.10.4 ThermoFisher Response to COVID-19 and Related Developments
7.11 Biokit
7.11.1 Biokit Business Overview
7.11.2 Biokit Human Immunodeficiency Virus Testing Quarterly Revenue, 2020
7.11.3 Biokit Human Immunodeficiency Virus Testing Product Introduction
7.11.4 Biokit Response to COVID-19 and Related Developments
7.12 Nectar Lifesciences
7.12.1 Nectar Lifesciences Business Overview
7.12.2 Nectar Lifesciences Human Immunodeficiency Virus Testing Quarterly Revenue, 2020
7.12.3 Nectar Lifesciences Human Immunodeficiency Virus Testing Product Introduction
7.12.4 Nectar Lifesciences Response to COVID-19 and Related Developments
7.13 ELITech Group
7.13.1 ELITech Group Business Overview
7.13.2 ELITech Group Human Immunodeficiency Virus Testing Quarterly Revenue, 2020
7.13.3 ELITech Group Human Immunodeficiency Virus Testing Product Introduction
7.13.4 ELITech Group Response to COVID-19 and Related Developments
7.14 Chembio Diagnostic Systems
7.14.1 Chembio Diagnostic Systems Business Overview
7.14.2 Chembio Diagnostic Systems Human Immunodeficiency Virus Testing Quarterly Revenue, 2020
7.14.3 Chembio Diagnostic Systems Human Immunodeficiency Virus Testing Product Introduction
7.14.4 Chembio Diagnostic Systems Response to COVID-19 and Related Developments
7.15 Trinity Biotech
7.15.1 Trinity Biotech Business Overview
7.15.2 Trinity Biotech Human Immunodeficiency Virus Testing Quarterly Revenue, 2020
7.15.3 Trinity Biotech Human Immunodeficiency Virus Testing Product Introduction
7.15.4 Trinity Biotech Response to COVID-19 and Related Developments
8 KEY FINDINGS
9 APPENDIX
9.1 About US
9.2 Disclaimer
LIST OF TABLES
Table 1. Overview of the World Economic Outlook Projections
Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)
Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 7. Covid-19 Impact: Global Major Government Policy
Table 8. The Covid-19 Impact on Human Immunodeficiency Virus Testing Assessment
Table 9. COVID-19 Impact: Human Immunodeficiency Virus Testing Market Trends
Table 10. COVID-19 Impact Global Human Immunodeficiency Virus Testing Market Size
Table 11. Global Human Immunodeficiency Virus Testing Quarterly Market Size, 2020 (US$ Million)
Table 12. Global Human Immunodeficiency Virus Testing Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million)
Table 13. Global Human Immunodeficiency Virus Testing Market Growth Drivers
Table 14. Global Human Immunodeficiency Virus Testing Market Restraints
Table 15. Global Human Immunodeficiency Virus Testing Market Opportunities
Table 16. Global Human Immunodeficiency Virus Testing Market Challenges
Table 17. By Players, Human Immunodeficiency Virus Testing Quarterly Revenue, 2019 VS 2020 (US$ Million)
Table 18. Key Players, Human Immunodeficiency Virus Testing Revenue Market Share, 2019 VS 2020 (%)
Table 19. Key Human Immunodeficiency Virus Testing Players Headquarters and Area Served
Table 20. Date of Key Players Enter into Human Immunodeficiency Virus Testing Market
Table 21. Key Players Human Immunodeficiency Virus Testing Product Type
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. By Players, Global Human Immunodeficiency Virus Testing Market Size 2019-2021, (US$ Million)
Table 24. Global Human Immunodeficiency Virus Testing Market Size by Application: 2019-2021 (US$ Million)
Table 25. Global Human Immunodeficiency Virus Testing Market Size by Region, 2019-2021 (US$ Million)
Table 26. By Country, North America Human Immunodeficiency Virus Testing Market Size, 2019-2021 (US$ Million)
Table 27. By Type, US Human Immunodeficiency Virus Testing Market Size, 2019-2021 (US$ Million)
Table 28. By Application, US Human Immunodeficiency Virus Testing Market Size, 2019-2021 (US$ Million)
Table 29. By Type, Canada Human Immunodeficiency Virus Testing Market Size, 2019-2021 (US$ Million)
Table 30. By Application, Canada Human Immunodeficiency Virus Testing Market Size, 2019-2021 (US$ Million)
Table 31. Macroeconomic Indicators of Europe (Germany, France, UK and Italy)
Table 32. By Country, Europe Human Immunodeficiency Virus Testing Market Size, 2019-2021 (US$ Million)
Table 33. By Type, Germany Human Immunodeficiency Virus Testing Market Size, 2019-2021 (US$ Million)
Table 34. By Application, Germany Human Immunodeficiency Virus Testing Market Size, 2019-2021 (US$ Million)
Table 35. By Type, France Human Immunodeficiency Virus Testing Market Size, 2019-2021 (US$ Million)
Table 36. By Application, France Human Immunodeficiency Virus Testing Market Size, 2019-2021 (US$ Million)
Table 37. By Type, UK Human Immunodeficiency Virus Testing Market Size, 2019-2021 (US$ Million)
Table 38. By Application, UK Human Immunodeficiency Virus Testing Market Size, 2019-2021 (US$ Million)
Table 39. By Type, Italy Human Immunodeficiency Virus Testing Market Size, 2019-2021 (US$ Million)
Table 40. By Application, Italy Human Immunodeficiency Virus Testing Market Size, 2019-2021 (US$ Million)
Table 41. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN)
Table 42. By Region, Asia-Pacific Human Immunodeficiency Virus Testing Market Size, 2019-2021 (US$ Million)
Table 43. By Type, China Human Immunodeficiency Virus Testing Market Size, 2019-2021 (US$ Million)
Table 44. By Application, China Human Immunodeficiency Virus Testing Market Size, 2019-2021 (US$ Million)
Table 45. By Type, Japan Human Immunodeficiency Virus Testing Market Size, 2019-2021 (US$ Million)
Table 46. By Application, Japan Human Immunodeficiency Virus Testing Market Size, 2019-2021 (US$ Million)
Table 47. By Type, South Korea Human Immunodeficiency Virus Testing Market Size, 2019-2021 (US$ Million)
Table 48. By Application, South Korea Human Immunodeficiency Virus Testing Market Size, 2019-2021 (US$ Million)
Table 49. By Type, India Human Immunodeficiency Virus Testing Market Size, 2019-2021 (US$ Million)
Table 50. By Application, India Human Immunodeficiency Virus Testing Market Size, 2019-2021 (US$ Million)
Table 51. By Type, ASEAN Human Immunodeficiency Virus Testing Market Size, 2019-2021 (US$ Million)
Table 52. By Application, ASEAN Human Immunodeficiency Virus Testing Market Size, 2019-2021 (US$ Million)
Table 53. By Type, Latin America Human Immunodeficiency Virus Testing Market Size, 2019-2021 (US$ Million)
Table 54. By Application, Latin America Human Immunodeficiency Virus Testing Market Size, 2019-2021 (US$ Million)
Table 55. By Type, Middle East and Africa Human Immunodeficiency Virus Testing Market Size, 2019-2021 (US$ Million)
Table 56. By Application, Middle East and Africa Human Immunodeficiency Virus Testing Market Size, 2019-2021 (US$ Million)
Table 57. Roche Business Overview
Table 58. Roche Human Immunodeficiency Virus Testing Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 59. Roche Human Immunodeficiency Virus Testing Product
Table 60. Roche Response to COVID-19 and Related Developments
Table 61. Abbott Business Overview
Table 62. Abbott Human Immunodeficiency Virus Testing Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 63. Abbott Human Immunodeficiency Virus Testing Product
Table 64. Abbott Response to COVID-19 and Related Developments
Table 65. Bio-Rad Business Overview
Table 66. Bio-Rad Human Immunodeficiency Virus Testing Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 67. Bio-Rad Human Immunodeficiency Virus Testing Product
Table 68. Bio-Rad Response to COVID-19 and Related Developments
Table 69. WanTai BioPharm Business Overview
Table 70. WanTai BioPharm Human Immunodeficiency Virus Testing Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 71. WanTai BioPharm Human Immunodeficiency Virus Testing Product
Table 72. WanTai BioPharm Response to COVID-19 and Related Developments
Table 73. Beckman Coulter Business Overview
Table 74. Beckman Coulter Human Immunodeficiency Virus Testing Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 75. Beckman Coulter Human Immunodeficiency Virus Testing Product
Table 76. Beckman Coulter Response to COVID-19 and Related Developments
Table 77. BD Business Overview
Table 78. BD Human Immunodeficiency Virus Testing Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 79. BD Human Immunodeficiency Virus Testing Product
Table 80. BD Response to COVID-19 and Related Developments
Table 81. Kehua Business Overview
Table 82. Kehua Human Immunodeficiency Virus Testing Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 83. Kehua Human Immunodeficiency Virus Testing Product
Table 84. Kehua Response to COVID-19 and Related Developments
Table 85. Livzon Business Overview
Table 86. Livzon Human Immunodeficiency Virus Testing Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 87. Livzon Human Immunodeficiency Virus Testing Product
Table 88. Livzon Response to COVID-19 and Related Developments
Table 89. Intec Business Overview
Table 90. Intec Human Immunodeficiency Virus Testing Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 91. Intec Human Immunodeficiency Virus Testing Product
Table 92. Intec Response to COVID-19 and Related Developments
Table 93. ThermoFisher Business Overview
Table 94. ThermoFisher Human Immunodeficiency Virus Testing Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 95. ThermoFisher Human Immunodeficiency Virus Testing Product
Table 96. ThermoFisher Response to COVID-19 and Related Developments
Table 97. Biokit Business Overview
Table 98. Biokit Human Immunodeficiency Virus Testing Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 99. Biokit Human Immunodeficiency Virus Testing Product
Table 100. Biokit Response to COVID-19 and Related Developments
Table 101. Nectar Lifesciences Business Overview
Table 102. Nectar Lifesciences Human Immunodeficiency Virus Testing Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 103. Nectar Lifesciences Human Immunodeficiency Virus Testing Product
Table 104. Nectar Lifesciences Response to COVID-19 and Related Developments
Table 105. ELITech Group Business Overview
Table 106. ELITech Group Human Immunodeficiency Virus Testing Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 107. ELITech Group Human Immunodeficiency Virus Testing Product
Table 108. ELITech Group Response to COVID-19 and Related Developments
Table 109. Chembio Diagnostic Systems Business Overview
Table 110. Chembio Diagnostic Systems Human Immunodeficiency Virus Testing Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 111. Chembio Diagnostic Systems Human Immunodeficiency Virus Testing Product
Table 112. Chembio Diagnostic Systems Response to COVID-19 and Related Developments
Table 113. Trinity Biotech Business Overview
Table 114. Trinity Biotech Human Immunodeficiency Virus Testing Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 115. Trinity Biotech Human Immunodeficiency Virus Testing Product
Table 116. Trinity Biotech Response to COVID-19 and Related Developments
Table 1. Overview of the World Economic Outlook Projections
Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)
Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 7. Covid-19 Impact: Global Major Government Policy
Table 8. The Covid-19 Impact on Human Immunodeficiency Virus Testing Assessment
Table 9. COVID-19 Impact: Human Immunodeficiency Virus Testing Market Trends
Table 10. COVID-19 Impact Global Human Immunodeficiency Virus Testing Market Size
Table 11. Global Human Immunodeficiency Virus Testing Quarterly Market Size, 2020 (US$ Million)
Table 12. Global Human Immunodeficiency Virus Testing Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million)
Table 13. Global Human Immunodeficiency Virus Testing Market Growth Drivers
Table 14. Global Human Immunodeficiency Virus Testing Market Restraints
Table 15. Global Human Immunodeficiency Virus Testing Market Opportunities
Table 16. Global Human Immunodeficiency Virus Testing Market Challenges
Table 17. By Players, Human Immunodeficiency Virus Testing Quarterly Revenue, 2019 VS 2020 (US$ Million)
Table 18. Key Players, Human Immunodeficiency Virus Testing Revenue Market Share, 2019 VS 2020 (%)
Table 19. Key Human Immunodeficiency Virus Testing Players Headquarters and Area Served
Table 20. Date of Key Players Enter into Human Immunodeficiency Virus Testing Market
Table 21. Key Players Human Immunodeficiency Virus Testing Product Type
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. By Players, Global Human Immunodeficiency Virus Testing Market Size 2019-2021, (US$ Million)
Table 24. Global Human Immunodeficiency Virus Testing Market Size by Application: 2019-2021 (US$ Million)
Table 25. Global Human Immunodeficiency Virus Testing Market Size by Region, 2019-2021 (US$ Million)
Table 26. By Country, North America Human Immunodeficiency Virus Testing Market Size, 2019-2021 (US$ Million)
Table 27. By Type, US Human Immunodeficiency Virus Testing Market Size, 2019-2021 (US$ Million)
Table 28. By Application, US Human Immunodeficiency Virus Testing Market Size, 2019-2021 (US$ Million)
Table 29. By Type, Canada Human Immunodeficiency Virus Testing Market Size, 2019-2021 (US$ Million)
Table 30. By Application, Canada Human Immunodeficiency Virus Testing Market Size, 2019-2021 (US$ Million)
Table 31. Macroeconomic Indicators of Europe (Germany, France, UK and Italy)
Table 32. By Country, Europe Human Immunodeficiency Virus Testing Market Size, 2019-2021 (US$ Million)
Table 33. By Type, Germany Human Immunodeficiency Virus Testing Market Size, 2019-2021 (US$ Million)
Table 34. By Application, Germany Human Immunodeficiency Virus Testing Market Size, 2019-2021 (US$ Million)
Table 35. By Type, France Human Immunodeficiency Virus Testing Market Size, 2019-2021 (US$ Million)
Table 36. By Application, France Human Immunodeficiency Virus Testing Market Size, 2019-2021 (US$ Million)
Table 37. By Type, UK Human Immunodeficiency Virus Testing Market Size, 2019-2021 (US$ Million)
Table 38. By Application, UK Human Immunodeficiency Virus Testing Market Size, 2019-2021 (US$ Million)
Table 39. By Type, Italy Human Immunodeficiency Virus Testing Market Size, 2019-2021 (US$ Million)
Table 40. By Application, Italy Human Immunodeficiency Virus Testing Market Size, 2019-2021 (US$ Million)
Table 41. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN)
Table 42. By Region, Asia-Pacific Human Immunodeficiency Virus Testing Market Size, 2019-2021 (US$ Million)
Table 43. By Type, China Human Immunodeficiency Virus Testing Market Size, 2019-2021 (US$ Million)
Table 44. By Application, China Human Immunodeficiency Virus Testing Market Size, 2019-2021 (US$ Million)
Table 45. By Type, Japan Human Immunodeficiency Virus Testing Market Size, 2019-2021 (US$ Million)
Table 46. By Application, Japan Human Immunodeficiency Virus Testing Market Size, 2019-2021 (US$ Million)
Table 47. By Type, South Korea Human Immunodeficiency Virus Testing Market Size, 2019-2021 (US$ Million)
Table 48. By Application, South Korea Human Immunodeficiency Virus Testing Market Size, 2019-2021 (US$ Million)
Table 49. By Type, India Human Immunodeficiency Virus Testing Market Size, 2019-2021 (US$ Million)
Table 50. By Application, India Human Immunodeficiency Virus Testing Market Size, 2019-2021 (US$ Million)
Table 51. By Type, ASEAN Human Immunodeficiency Virus Testing Market Size, 2019-2021 (US$ Million)
Table 52. By Application, ASEAN Human Immunodeficiency Virus Testing Market Size, 2019-2021 (US$ Million)
Table 53. By Type, Latin America Human Immunodeficiency Virus Testing Market Size, 2019-2021 (US$ Million)
Table 54. By Application, Latin America Human Immunodeficiency Virus Testing Market Size, 2019-2021 (US$ Million)
Table 55. By Type, Middle East and Africa Human Immunodeficiency Virus Testing Market Size, 2019-2021 (US$ Million)
Table 56. By Application, Middle East and Africa Human Immunodeficiency Virus Testing Market Size, 2019-2021 (US$ Million)
Table 57. Roche Business Overview
Table 58. Roche Human Immunodeficiency Virus Testing Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 59. Roche Human Immunodeficiency Virus Testing Product
Table 60. Roche Response to COVID-19 and Related Developments
Table 61. Abbott Business Overview
Table 62. Abbott Human Immunodeficiency Virus Testing Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 63. Abbott Human Immunodeficiency Virus Testing Product
Table 64. Abbott Response to COVID-19 and Related Developments
Table 65. Bio-Rad Business Overview
Table 66. Bio-Rad Human Immunodeficiency Virus Testing Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 67. Bio-Rad Human Immunodeficiency Virus Testing Product
Table 68. Bio-Rad Response to COVID-19 and Related Developments
Table 69. WanTai BioPharm Business Overview
Table 70. WanTai BioPharm Human Immunodeficiency Virus Testing Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 71. WanTai BioPharm Human Immunodeficiency Virus Testing Product
Table 72. WanTai BioPharm Response to COVID-19 and Related Developments
Table 73. Beckman Coulter Business Overview
Table 74. Beckman Coulter Human Immunodeficiency Virus Testing Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 75. Beckman Coulter Human Immunodeficiency Virus Testing Product
Table 76. Beckman Coulter Response to COVID-19 and Related Developments
Table 77. BD Business Overview
Table 78. BD Human Immunodeficiency Virus Testing Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 79. BD Human Immunodeficiency Virus Testing Product
Table 80. BD Response to COVID-19 and Related Developments
Table 81. Kehua Business Overview
Table 82. Kehua Human Immunodeficiency Virus Testing Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 83. Kehua Human Immunodeficiency Virus Testing Product
Table 84. Kehua Response to COVID-19 and Related Developments
Table 85. Livzon Business Overview
Table 86. Livzon Human Immunodeficiency Virus Testing Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 87. Livzon Human Immunodeficiency Virus Testing Product
Table 88. Livzon Response to COVID-19 and Related Developments
Table 89. Intec Business Overview
Table 90. Intec Human Immunodeficiency Virus Testing Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 91. Intec Human Immunodeficiency Virus Testing Product
Table 92. Intec Response to COVID-19 and Related Developments
Table 93. ThermoFisher Business Overview
Table 94. ThermoFisher Human Immunodeficiency Virus Testing Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 95. ThermoFisher Human Immunodeficiency Virus Testing Product
Table 96. ThermoFisher Response to COVID-19 and Related Developments
Table 97. Biokit Business Overview
Table 98. Biokit Human Immunodeficiency Virus Testing Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 99. Biokit Human Immunodeficiency Virus Testing Product
Table 100. Biokit Response to COVID-19 and Related Developments
Table 101. Nectar Lifesciences Business Overview
Table 102. Nectar Lifesciences Human Immunodeficiency Virus Testing Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 103. Nectar Lifesciences Human Immunodeficiency Virus Testing Product
Table 104. Nectar Lifesciences Response to COVID-19 and Related Developments
Table 105. ELITech Group Business Overview
Table 106. ELITech Group Human Immunodeficiency Virus Testing Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 107. ELITech Group Human Immunodeficiency Virus Testing Product
Table 108. ELITech Group Response to COVID-19 and Related Developments
Table 109. Chembio Diagnostic Systems Business Overview
Table 110. Chembio Diagnostic Systems Human Immunodeficiency Virus Testing Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 111. Chembio Diagnostic Systems Human Immunodeficiency Virus Testing Product
Table 112. Chembio Diagnostic Systems Response to COVID-19 and Related Developments
Table 113. Trinity Biotech Business Overview
Table 114. Trinity Biotech Human Immunodeficiency Virus Testing Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 115. Trinity Biotech Human Immunodeficiency Virus Testing Product
Table 116. Trinity Biotech Response to COVID-19 and Related Developments
LIST OF FIGURES
Figure 1. Human Immunodeficiency Virus Testing Product Picture
Figure 2. Human Immunodeficiency Virus Testing Market Segmentation
Figure 3. Research Objectives
Figure 4. Research Process
Figure 5. Data Triangulation
Figure 6. Research Approach
Figure 7. Commodity Prices-Metals Price Indices
Figure 8. Commodity Prices- Precious Metal Price Indices
Figure 9. Commodity Prices- Agricultural Raw Material Price Indices
Figure 10. Commodity Prices- Food and Beverage Price Indices
Figure 11. Commodity Prices- Fertilizer Price Indices
Figure 12. Commodity Prices- Energy Price Indices
Figure 13. G20+: Economic Policy Responses to COVID-19
Figure 14. Global Human Immunodeficiency Virus Testing Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million)
Figure 15. Global Human Immunodeficiency Virus Testing Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%)
Figure 16. Global Human Immunodeficiency Virus Testing Market Size, Quarterly Growth, 2020-2021 (%)
Figure 17. Global Human Immunodeficiency Virus Testing Market Size, Market Share by Type, 2019 VS 2020 (%)
Figure 18. Global Human Immunodeficiency Virus Testing Market Size, Market Share by Application, 2019 VS 2020 (%)
Figure 19. Global Human Immunodeficiency Virus Testing Market Size Market Share by Region, 2019 VS 2020 (%)
Figure 20. United States Composite PMI and GDP
Figure 21. Eurozone Composite PMI and GDP
Figure 22. Eurozone Core v. Periphery PMI Output Indices
Figure 23. Core v. Periphery PMI Employment Indices
Figure 24. UK Composite PMI and GDP
Figure 25. Caixin China Composite Output Index
Figure 26. Caixin China General Services Business Activity Index
Figure 27. Japan Composite Output Index
Figure 28. South Korea Manufacturing PMI
Figure 29. India Composite Output Index
Figure 30. ASEAN Manufacturing PMI
Figure 31. By Region, Asia-Pacific Human Immunodeficiency Virus Testing Market Size Market Share, 2019-2021
Figure 1. Human Immunodeficiency Virus Testing Product Picture
Figure 2. Human Immunodeficiency Virus Testing Market Segmentation
Figure 3. Research Objectives
Figure 4. Research Process
Figure 5. Data Triangulation
Figure 6. Research Approach
Figure 7. Commodity Prices-Metals Price Indices
Figure 8. Commodity Prices- Precious Metal Price Indices
Figure 9. Commodity Prices- Agricultural Raw Material Price Indices
Figure 10. Commodity Prices- Food and Beverage Price Indices
Figure 11. Commodity Prices- Fertilizer Price Indices
Figure 12. Commodity Prices- Energy Price Indices
Figure 13. G20+: Economic Policy Responses to COVID-19
Figure 14. Global Human Immunodeficiency Virus Testing Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million)
Figure 15. Global Human Immunodeficiency Virus Testing Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%)
Figure 16. Global Human Immunodeficiency Virus Testing Market Size, Quarterly Growth, 2020-2021 (%)
Figure 17. Global Human Immunodeficiency Virus Testing Market Size, Market Share by Type, 2019 VS 2020 (%)
Figure 18. Global Human Immunodeficiency Virus Testing Market Size, Market Share by Application, 2019 VS 2020 (%)
Figure 19. Global Human Immunodeficiency Virus Testing Market Size Market Share by Region, 2019 VS 2020 (%)
Figure 20. United States Composite PMI and GDP
Figure 21. Eurozone Composite PMI and GDP
Figure 22. Eurozone Core v. Periphery PMI Output Indices
Figure 23. Core v. Periphery PMI Employment Indices
Figure 24. UK Composite PMI and GDP
Figure 25. Caixin China Composite Output Index
Figure 26. Caixin China General Services Business Activity Index
Figure 27. Japan Composite Output Index
Figure 28. South Korea Manufacturing PMI
Figure 29. India Composite Output Index
Figure 30. ASEAN Manufacturing PMI
Figure 31. By Region, Asia-Pacific Human Immunodeficiency Virus Testing Market Size Market Share, 2019-2021
